Raiffeisen Bank International AG acquired a new stake in Core Laboratories Inc. (NYSE:CLB – Free Report) during the 4th quarter, Holdings Channel reports. The institutional investor acquired 99,963 shares of the oil and gas company’s stock, valued at approximately $1,706,000.
Other hedge funds also recently added to or reduced their stakes in the company. Point72 Asset Management L.P. purchased a new stake in shares of Core Laboratories during the fourth quarter worth about $266,000. ProShare Advisors LLC acquired a new position in shares of Core Laboratories during the fourth quarter worth approximately $245,000. Quantinno Capital Management LP acquired a new position in shares of Core Laboratories during the fourth quarter worth approximately $195,000. Millennium Management LLC raised its holdings in Core Laboratories by 429.0% during the fourth quarter. Millennium Management LLC now owns 65,616 shares of the oil and gas company’s stock worth $1,136,000 after purchasing an additional 53,213 shares in the last quarter. Finally, MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. raised its holdings in Core Laboratories by 3.7% during the fourth quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 26,723 shares of the oil and gas company’s stock worth $463,000 after purchasing an additional 960 shares in the last quarter. 97.81% of the stock is owned by hedge funds and other institutional investors.
Analysts Set New Price Targets
CLB has been the topic of several research reports. Stifel Nicolaus dropped their price target on Core Laboratories from $19.00 to $15.00 and set a “hold” rating on the stock in a report on Tuesday, April 15th. Citigroup dropped their price target on Core Laboratories from $16.00 to $13.00 and set a “neutral” rating on the stock in a report on Tuesday. Finally, StockNews.com downgraded shares of Core Laboratories from a “hold” rating to a “sell” rating in a research note on Friday, April 25th. Two equities research analysts have rated the stock with a sell rating and three have given a hold rating to the company’s stock. According to MarketBeat.com, the company has a consensus rating of “Hold” and an average target price of $15.00.
Core Laboratories Trading Up 0.2%
Core Laboratories stock opened at $11.89 on Friday. The stock has a market cap of $557.35 million, a P/E ratio of 18.01, a P/E/G ratio of 0.99 and a beta of 1.45. Core Laboratories Inc. has a 12 month low of $10.14 and a 12 month high of $25.13. The company’s fifty day simple moving average is $13.01 and its 200-day simple moving average is $16.48. The company has a quick ratio of 1.71, a current ratio of 2.32 and a debt-to-equity ratio of 0.49.
Core Laboratories (NYSE:CLB – Get Free Report) last issued its quarterly earnings data on Wednesday, April 23rd. The oil and gas company reported $0.14 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.15 by ($0.01). The business had revenue of $123.59 million during the quarter, compared to the consensus estimate of $125.09 million. Core Laboratories had a return on equity of 16.24% and a net margin of 5.99%. The company’s revenue for the quarter was down 4.7% on a year-over-year basis. During the same quarter in the prior year, the company posted $0.19 earnings per share. As a group, sell-side analysts forecast that Core Laboratories Inc. will post 0.96 EPS for the current fiscal year.
Core Laboratories Dividend Announcement
The company also recently announced a quarterly dividend, which will be paid on Tuesday, May 27th. Shareholders of record on Monday, May 5th will be given a dividend of $0.01 per share. This represents a $0.04 dividend on an annualized basis and a yield of 0.34%. The ex-dividend date of this dividend is Monday, May 5th. Core Laboratories’s dividend payout ratio is 6.78%.
Core Laboratories Profile
Core Laboratories Inc provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, and internationally. It operates through Reservoir Description and Production Enhancement segments. The Reservoir Description segment includes the characterization of petroleum reservoir rock and reservoir fluid samples to enhance production and improve recovery of crude oil and gas from its clients' reservoirs.
Further Reading
- Five stocks we like better than Core Laboratories
- Earnings Per Share Calculator: How to Calculate EPS
- Meta’s 5 Key Pillars for AI Growth—Zuckerberg’s Bold Vision
- Quiet Period Expirations Explained
- Retail Investors Are Betting Big on Rocket Lab—Should You Too?
- Transportation Stocks Investing
- GE Aerospace: Qatar Deal Fuels Multi-Billion Dollar Growth Engine
Want to see what other hedge funds are holding CLB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Core Laboratories Inc. (NYSE:CLB – Free Report).
Receive News & Ratings for Core Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Core Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.